₹2,000 crore. With the acquisition, Torrent Pharma will add a Field Force of 600 MRs and a distribution network of 900 stockists. “Torrent Pharmaceuticals Limited (Torrent Pharma) has entered into definitive agreements to acquire 100% of Curatio Healthcare (I) Private Limited (Curatio) for Rs.
2,000 crores," the company said in a regulatory filing. The consideration includes ₹115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of ₹1,885 crore, the company said.
Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands, marketed in India. The dermatology company's portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst top 5 brands in their covered market.
Top ten brands of Curatio account for 75% of total revenue. Curatio’s revenue for FY22 came at ₹224 crore. With YTD August sales up 25%, Curatio is expected to cross ₹275 crore revenue in FY23.